Prolactin (PRL), acting via the PRL receptor (PRLR), controls hundreds of biological processes across a range of species. Endocrine PRL elicits well-documented effects on target tissues such as the mammary glands and reproductive organs in addition to coordinating wholebody homeostasis during states such as lactation or adaptive responses to the environment. While changes in PRLR expression likely facilitates these tissue-specific responses to circulating PRL, the mechanisms regulating this regulation in non-rodent species has received limited attention. We performed a wide-scale analysis of PRLR 5 0 transcriptional regulation in pig tissues. Apart from the abundantly expressed and widely conserved exon 1, we identified alternative splicing of transcripts from an additional nine first exons of the porcine PRLR (pPRLR) gene. Notably, exon 1.5 transcripts were expressed most abundantly in the heart, while expression of exon 1.3-containing transcripts was greatest in the kidneys and small intestine. Expression of exon 1.3 mRNAs within the kidneys was most abundant in the renal cortex, and increased during gestation. A comparative analysis revealed a human homologue to exon 1.3, hE1 N2 , which was also principally transcribed in the kidneys and small intestines, and an exon hE1 N3 was only expressed in the kidneys of humans. Promoter alignment revealed conserved motifs within the proximal promoter upstream of exon 1.3, including putative binding sites for hepatocyte nuclear factor-1 and Sp1. Together, these results highlight the diverse, conserved and tissue-specific regulation of PRLR expression in the targets for PRL, which may function to coordinate complex physiological states such as lactation and osmoregulation.
Introduction
A successful lactation requires mammary epithelial cells to proliferate and then differentiate in preparation for the synthesis and secretion of milk (Hovey & Trott 2004) , while peripheral organs coordinately absorb, metabolise and/or mobilise a massive amount of various nutrients including water to support lactation. As has been established for lactating dairy animals, the systemic coordination of nutrient uptake and mobilisation occurs in liver, muscle and adipose tissues during homeorhetic and homeostatic processes in support of lactation (Bauman & Currie 1980 , Loor 2010 . However, the mechanisms that coordinate and regulate these processes as well as the uptake and/or redistribution of other components in milk, such as water and ions, such as sodium and calcium, are not well understood in any species.
One hormone that can participate in the regulation of these processes and that fulfils O300 physiological functions across a broad range of species (Bole-Feysot et al. 1998 ) is the polypeptide hormone prolactin (PRL), which is secreted by lactotrophs in the anterior pituitary (Freeman et al. 2000) . PRL stimulates the uptake of calcium, which is a major ion in milk, in the small intestine (Jantarajit et al. 2007 , Ryszka et al. 2012 ) and interacts with the renal dopamine system to effect natriuresis in the kidneys (Ibarra et al. 2005) . The prepartum surge of PRL that is essential for the subsequent lactation also likely increases blood flow to the mammary gland (MG) at the onset of lactation (Hanwell & Linzell 1973 , Peaker 1976 , Ota & Peaker 1979 , given that PRL increases various measures of cardiac output (Nassar et al. 1974 , Karmazyn et al. 1982 . Both of these functions are peripheral to the major role of PRL in the development and differentiation of the MG and the stimulation of lactation (Trott et al. 2012) . Ironically, the regulation of PRL receptor (PRLR) expression in tissues peripheral to the MG is almost completely unknown in most species, including humans.
Information regarding the physiological and genomic regulation of PRLR expression in vivo has mostly stemmed from data for rodents (Hu et al. 1996 , 1998 , Tabata et al. 2012 , Hirai et al. 2013 , or has specifically focused on PRLR expression in cancer cells in vitro and the response to stimulation by ovarian hormones (Hu et al. 2002 , Dong et al. 2006 ). More than one promoter has been identified within the PRLR gene of mice (Ormandy et al. 1998) , rats (Hu et al. 1998 ) and humans (Hu et al. 2002) , although limited data exist regarding the activity of these known first exon promoters in different tissues from these species. Furthermore, while there are commonalities between these species, as to which tissues express PRLR (Bole-Feysot et al. 1998) , there also are differences such as low expression of PRLR in the liver and ovaries of humans vs notably higher levels in rodents (Nagano & Kelly 1994 , Peirce & Chen 2001 . Thus, studies of how PRLR expression is regulated during various physiologic states in humans may not be closely recapitulated in rodents.
Pigs have become an increasingly important biomedical model, given that they are genetically more similar to humans than mice (Wernersson et al. 2005) and are physiologically similar to humans (Swindle et al. 2012) . Expression of the long form of the porcine PRLR (pPRLR) is differentially expressed in the pig in a tissue and cell-type specific manner (Trott et al. 2009 ), which is similar to that described for humans (Peirce & Chen 2001) . Furthermore, we previously identified a homologous first exon promoter for the pPRLR (Schennink et al. 2013 ) that is expressed most abundantly in primary PRL targets such as the MG, adrenal glands, placenta, endometrium and pituitary, as well as the regulation of PRLR expression by estrogen. Given that various tissues differentially modulate their PRLR expression during states such as lactation (Jahn et al. 1991 , Ling et al. 2000 and in response to hormonal stimulation (Trott et al. 2009 ), we hypothesised that multiple promoters direct pPRLR expression in a tissue-specific manner.
Using 5 0 RACE, we performed the most comprehensive screen to date of 5 0 PRLR gene regulation across tissues for any species. Among the nine new first-PRLR exons we identified, we found that expression of one first exon, pE1.3, was primarily expressed in the kidney cortex and small intestine, where a homologous first exon, hE1 N2 , is uniquely expressed in these same tissues in humans. Furthermore, we show that certain transcripts encoding pE1.5 are restricted to expression in the heart, which further emphasises a potential role for PRL in the regulation of cardiac function.
Materials and methods

Animals
Experiments were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals, as approved by the Institutional Animal Care and Use Committee at UC Davis. Nulliparous Hampshire!Yorkshire female pigs (nZ11) were housed, killed and tissues sampled as described previously (Trott et al. 2011) . The pregnant pigs were unilaterally hysterectomised-ovariectomised and then killed at different stages of gestation, as described previously (Freking et al. 2007 , Trott et al. 2009 ).
RNA extraction, RT and 5 0 RACE
Extraction of porcine RNA and generation of cDNA were performed as described previously (Schennink et al. 2013) . Human RNA (0.5 mg) from the Human total RNA master panel I (Clontech) was subjected to RT as described previously (Schennink et al. 2013) . We performed 5 0 RACE as described previously (Schennink et al. 2013) using poly AC RNA from pig MG, placenta, liver, kidney, adrenal, ovary and testis using the SMARTer RACE cDNA Amplification Kit (Clontech) and the primers GSP1a (5 0 -CG-GAGGTGACTGTCCATTCAGAAGGCTG-3 0 ; exons 3/4) and NGSP1a (5 0 -TTGGCTCCCTTCTCTTTCCACAGG-CAG-3 0 ; exon 3) designed from the pPRLR (GenBank NM_001001868).
Cloning pig exon 1 transcripts
The primer pairs were designed to span either from exon 1 of pPRLR to the junction of exons 3/4, or from exon 1 to the junction of exons 2.1/3 (Table 1) in an attempt to clone three splice variants for each exon 1. The transcripts of pPRLR were generated by PCR of cDNA prepared from multiple pig tissues (Table 1) , gel purified, cloned into pCR2.1 TOPO (Life Technologies) and sequenced.
Quantitative PCR
The primer sequences used to amplify pPRLR first exon splice variants are presented in Table 2 . Quantitative PCRs were performed as described previously (Schennink et al. 2013) , using the T m in Table 2 for the combined annealing and extension step. Standard curves were prepared as tenfold serial dilutions (10-10 7 copies/well) of each pPRLR cDNA transcript that had been cloned into pCR2.1-TOPO and then spiked into either mouse liver cDNA or tRNA (10 ng/ml, Ambion, Carlsbad, CA, USA). The standards were assayed in duplicate or triplicate. The expression levels of each transcript were calculated using an absolute quantification standard curve of cycles to threshold vs plasmid copy number (log 10 transformed). A relative standard curve for 18S rRNA was also prepared using fivefold serial dilutions of pooled cDNA that were amplified in duplicate using previously published primers (Trott et al. 2011) . All standard curves had a linear regression coefficient of determination of at least 99.1%. The average transcript copy number, determined from duplicates, was divided by the corresponding relative amount of 18S rRNA (Trott et al. 2011) .
Promoter and first exon sequence homology
The NCBI BLAST programme (http://blast.ncbi.nlm.nih. gov/Blast.cgi) was used to search genomic sequences for homologues to the porcine first exon sequences. The promoter sequences (2000 bp upstream) for Sus scrofa (pig), Canis lupus familiaris (dog), Bos taurus (cow), Papio anubio (olive baboon), Macaca mulatta (Rhesus monkey) and Homo sapiens (human) that were homologous to the pE1.3 first exon were downloaded from GenBank and aligned using Dalign to identify the regions of homology (Brudno et al. 2003) . We used AliBaba2.1 (http://www. gene-regulation.com/pub/programs/alibaba2/index.html) to predict transcription factor-binding sites from the 
Heatmap
To summarise the expression of all transcripts in all target tissues, the expression profiles were clustered in R using the 'gplots' library. The expression profiles were logtransformed. Distances between expression profiles were then calculated based on euclidian distances and hierarchical clustering of expression profiles was done using the 'hclust' algorithm.
Statistical analyses
Normality of data was tested using the univariate procedure of SASv9.3 and, where possible, data were transformed to normality using the transreg procedure of SASv9.3 and a Box-Cox power transformation (SAS Institute, Inc., Cary, NC, USA). The changes in transcript expression between tissues were assessed by two-way ANOVA using a general linear model procedure in SASv9.3 that included the effects of tissue and animal. Multiple comparisons were accounted for with Tukey adjustment (SAS Institute, Inc.). Results from quantitative PCR used to measure pPRLR expression in different regions of the kidney and small intestine were analyzed by Students' t-test. Differences were considered significant at P%0.05.
Results
Identification of nine pPRLR first exons by 5 0 RACE
To address the coordinated and systemic regulation of PRLR expression within individuals, we searched for all potential first exons of the PRLR in seven candidate PRLtarget tissues in pigs. From this analysis, we identified nine alternative first exon sequences in addition to the pE1 sequence we have recently described (Schennink et al. 2013) . These various first exons of the pPRLR are denoted as pE1.1-pE1.9 according to their order in the genome, and have the following GenBank accession numbers pE1.1 (KJ608380), pE1.2 (KJ608379), pE1.3 (KJ608375), pE1.4 (KJ608377), pE1.5 (KJ608373), pE1.6 (KJ608381), pE1.7 (KJ608376), pE1.8 (KJ608378) and pE1.9 (KJ608374). Alignment of pE1.1 and pE1.7 to the pig genome (Build 10.2; http://www.ncbi.nlm.nih.gov/ assembly/GCF_000003025.5/) revealed that each is divided into two exons by an intron, and thus were thereafter named pE1.1a and E1.1b and pE1.7a and E1.7b respectively. Given that S. scrofa genome lacks complete annotation, we determined the location and orientation of all ten first exons plus exons 2 and 2.1 on S. scrofa chromosome 16 (Schennink et al. 2013) , with the exception of pE1.5, which is likely located in a 50 kb gap between pE1.4 and pE1.6 that is present in the latest S. scrofa genome Build 10.2 (Fig. 1) . The orientation and locations of exons 3 through 11 on the reverse strand of chromosome 16 were as described previously (Trott et al. 2011) , which are in accordance with the hPRLR gene that is located on the reverse strand of H. sapiens chromosome 5. From our annotation ( Fig. 1) , it is evident that the segments including 21 608 065-21 631 107 bp (exons 1.6 through 2.1) and 21 742 631-21 787 592 bp (exons 1 through part of 1.4) of the current S. scrofa Build 10.2 are both incorrectly oriented ( Fig. 1) .
Given our previous demonstration that pE1 has multiple transcripts involving alternative splicing of exons 2 and 2.1 (Schennink et al. 2013) , we carried out PCR to find all possible splice variants involving first exons pE1.1b through pE1.9, and exons 2, 2.1 and 3. The splice variants pE1.4/2/2.1, pE1.8/3, pE1.8/2/2.1/3, pE1.9/2/3 and pE1.9/2/2.1/3 were undetectable in either adrenal, endometrium, kidney, liver, MG or ovary cDNA. The absence of pE1.9/2/3 and pE1.9/2/2.1/3 mRNA further confirmed that our genomic organisation of the pPRLR exons was correct (Fig. 1 ). The splice variant 1.7b/2/2.1/3 was undetectable in MG cDNA, leading us to conclude that none of these particular splice variants were transcribed at biologically significant levels; thus we did not pursue them further (data not shown). In Fig. 2 , we have illustrated the 24 known transcripts of pPRLR first exon splice variants involving splicing of exons 1, 2, 2.1 and 3 of the pPRLR both from this manuscript in addition to those reported by Schennink et al. (2013) .
Tissue-specific pPRLR transcript expression
We used qPCR to quantify the expression of all known pPRLR splice variants incorporating the nine new first exons that splice to exon 3, including or excluding exons 2 and 2.1. This analysis was performed on 18 tissues collected from the same individual pigs, which enabled us to assess the systemic, coordinated regulation of pPRLR transcription (Fig. 3 ). Nine clusters of splice variants having similar patterns of tissue-specific expression were identified (Fig. 3 ). Among these tissues, the mRNA for nine splice variants was most abundant in the MG, namely pE1.1b/3, pE1.1b/2/3, pE1.2/3, pE1.2/2/3, pE1.2/2/2.1/3, pE1.5/3, pE1.6/3, pE1.7b/3, pE1.9/3 ( Supplementary  Figures 1, 2 , 3, 4 and 5, see section on supplementary data given at the end of this article), where all but two of these are in clusters 1 and 6 ( Fig. 3 ). This abundant expression of the various pPRLR mRNAs in the MG was also previously shown for the pE1 splice variants (Schennink et al. 2013 The pig PRLR gene is located on the reverse strand of chromosome 16 and comprises nine coding (exons 3-11) and 14 non-coding exons. Intron lengths (bp) are indicated above the line while exon lengths (bp) are indicated below each box representing an exon. The physical and numbered location on chromosome 16 according to Build 10.2 of the Sus scrofa genome (http://www.ncbi.nlm.nih.gov/genome/84) is indicated with numbers and arrows, and is currently annotated as being split between the reverse strand (exons 1.9 through 11) and two sections of the forward strand (exons 1 through 2.1). The sections from 21 608 065 to 21 631 107 bp (exons 1.6 through 2.1) and 21 742 631 to 21 787 592 bp (exons 1 through part of 1.4) are both incorrectly oriented in the current S. scrofa Build 10.2 and ought to be on the reverse strand. The 290 bp polymorphic insertion in exon 11 (Trott et al. 2014 ) is indicated. Fig. 3 ) were considered together, there was a tendency towards their higher expression in the endometrium, kidney and small intestine (Supplementary Figure 6 ). Three other splice variants (pE1.5/2/2.1/3, pE1.6/2/2.1/3 and pE1.8/2/3) did not have any specificity in their expression across tissues ( Supplementary Figures 3, 4 and 5C). Two splice variants, pE1.1b/2/2.1/3 and pE1.7b/2/3, had fewer than 250 copies of mRNA/mg total RNA in all 18 tissues (data not shown). All tissues expressed the three transcripts in cluster 6, namely pE1.5/3 ( Supplementary  Figure 3 ), pE1.1b/3 ( Supplementary Figure 1 ) and pE1.9/3 (Supplementary Figure 5B) as their most-highly expressed transcripts ( Fig. 3) , except for lymph node, heart, kidney, small intestine and liver. While expression of pPRLR mRNA in the lymph node was generally low, there was enhanced expression of the pE1.6/3, but not the pE1.6/2/3 transcript, within this tissue ( Supplementary Figure 4) . Interestingly, the primary transcript expressed in the heart was pE1.5/2/3 ( Fig. 3) , which was present at levels O20-fold higher than in any other tissue ( Supplementary Figure 3 ; P!0.05). Separately, there was a unique, elevated expression of pE1.3containing transcripts in the kidneys, small intestine and liver (clusters 5 and 9, Fig. 3) , where the pE1.3/2/3 and pE1.3/3 transcripts were the major transcripts (Supplementary Figures 7) , with expression levels far-exceeding the expression levels of the three transcripts in cluster 6 that are the most highly-expressed transcripts in the other 13 tissues ( Fig. 3; and Supplementary Figures 1, 3 and 5B ).
Analysis of pE1.3 expression in pig kidney and small intestine
Given our novel finding that transcription of pE1.3 was tightly restricted to high levels of expression in the kidneys and small intestine, we investigated its distribution within these tissues given the important role for PRL in both these organs (Ryszka et al. 2012 , Wongdee & Charoenphandhu 2013 . Within the kidneys most pE1.3 mRNA was expressed in the cortex (Fig. 4) , with similar amounts (PZ0.7) in the outer and inner regions (126! 10 3 G7!10 3 copies pE1.3 mRNA/mg total RNA, and 131! 10 3 G13!10 3 copies pE1.3 mRNA/mg total RNA respectively). By contrast, much lower levels (P!0.001) were present in the medulla (3.0!10 3 G1.2!10 3 copies pE1.3 mRNA/mg total RNA) and pelvis (1.7!10 3 G0.7!10 3 copies pE1.3 mRNA/mg total RNA).
We next examined whether the expression of pE1.3 in the kidney changed during the transition from gestation to lactation given that renal function is dramatically increased during this window. Indeed, expression of pE1.3 mRNA in the kidney increased linearly during this period ( Fig. 5; PZ0.04 ). Finally, we assessed whether pE1.3 expression differed throughout the small intestine. In contrast to the kidney, we found no evidence for differential expression of pE1.3 mRNA between its three regions ( Fig. 6; PO0.18 ).
Homologous PRLR first exons are transcribed in the human
We compared the ten first exons of the pPRLR (the nine described herein plus pE1 (Schennink et al. 2013 )) with first exon PRLR sequences from the four species reported to have more than one first-exon, namely mouse, rat, human and chicken (Fig. 7) . The pE1 closely aligned to Diagrammatic illustration of the 24 known splice variants of the pig PRLR involving either exons 2/2, 1/3, 2/3 or splicing directly from exon 1 to 3 as found in this manuscript and in Schennink et al. (2013) .
rat E1 3 (rE1 3 ), mouse E1 3 (mE1 3 ) and human E1 3 (hE1 3 ) as previously described (Schennink et al. 2013) . Not surprisingly, for mice and rats, there was conservation of the first PRLR exons rE1 4 and mE1 4 , rE1 2 and mE1 2 , rE1 5 and mE1 5 , but these had no homology with any known human or pig first exons. Separately, we found that pE1.3 aligned with a PRLR first exon that was previously identified in humans, namely hE1 N2 (Hu et al. 2002) . Given the high level of genomic sequence identity between pigs and humans (Wernersson et al. 2005) , we hypothesised that sequence information for these ten pPRLR first exons would allow us to identify additional first exons that are transcribed from the human genome. Seven of the pig first exons shared some identity with sequences upstream of hPRLR exon 2. The similarity between these putative homologue pairs was 66% (pE1.6), 69% (pE1.3), 69% (pE1.4), 71% (pE1.2), 71% (pE1.5), 71% (pE1.8) and 74% (pE1). Two of these human sequences, namely hE1 N2 (homologous to pE1.3) and hE1 3 (homologous to pE1), were previously found to be expressed as first exons (Hu et al. 2002) . We also investigated whether the remaining putative homologues were expressed in humans by performing RT-PCR on 20 human tissues using primers in putative human exons 1.2, 1.4, 1.6 and 1.8 and exon 6, but did not record any evidence for the transcription of these exons (data not shown). Furthermore, primers positioned in the putative human exon 1.5 and exon 5 of the hPRLR did not amplify a PCR product from human heart cDNA (not shown). Finally, we found no evidence in GenBank for the expressed sequences of the candidate human first exon homologues 1.2, 1.4, 1.5, 1.6 or 1.8. From these collective findings, we presently deduce that only the homologous exons pE1.3/hE1 N2 and pE1/hE1 3 are expressed in both pigs and humans. Given the homology between pE1.3 and hE1 N2 and the pronounced tissue specificity of pE1.3 expression, we sought to determine whether hE1 N2 expression was also tissue-restricted in humans. Using PCR primers in hE1 N2 Heatmap of 19 pig PRLR first exon splice variants expressed in 18 different tissues. Each coloured square depicts the intensity of log-transformed transcript expression levels according to the colour key (creamZlowest expression, redZhighest expression). The dendrogram on the left side shows the distances between the expression profiles of different transcripts, while the dendrogram on the top shows the distances between the expression profiles of different tissues. Short branch lengths indicate smaller differences. Individual clusters one to nine are manually separated by white rows to highlight specific clusters of interest. A full colour version of this figure is available via http://dx.doi.org/10.1530/JME-14-0212. and exon 6, we identified three splice variants expressed in T47D cells, which included either hE1 N2 or hE1 N3 (GenBank KJ651922), hE1 N2 and a novel first exon we called hE1 N6 (GenBank KJ651923), or splicing directly from hE1 N2 to exon 2 and then exons 3-6 (GenBank KJ651924 ZOGP_9606_9558; 2 September 2014). This hE1 N6 sequence is located between hE1 N3 and hE1 N4 in the hPRLR gene. We also investigated whether hE1 N2 expression was the result of splicing from an upstream exon rather than due to independent hE1 N2 promoter activity. Given that the abundantly expressed exon hE1 3 lies upstream of hE1 N2 , we screened for transcripts starting with hE1 3 and splicing to hE1 N2 . Expression of the transcript including the hE1 3 -hE1 N2 sequence was highest in the adrenal gland, endometrium and placenta, and was undetectable in heart, skeletal muscle or spleen (Fig. 8) . These data proved that not all hE1 N2 expression was conferred by the hE1 N2 promoter, which led to the identification of an internal 3 0 splice site marked by a consensus CAG trinucleotide (Zhang 1998) . Given that transcription of first exon hPRLR mRNA downstream of the 3 0 splice site can be either from that first exon's promoter activity, or due to splicing from an upstream first exon, we determined whether any expression of hE1 N2 in human tissues, or for that matter hE1 N3 and the new exon hE1 N6 , was the result of their own promoter activity. We found that transcription of mRNA containing sequence upstream of the internal 3 0 splice site for hE1 N2 , hE1 N3 and hE1 N6 in 20 human tissues was much less than the corresponding expression level of mRNAs containing sequence downstream of the internal 3 0 splice site (data not shown). This finding strongly suggested that the activity of promoters associated with hE1 N2 , hE1 N3 and hE1 N6 could only be measured as the levels of transcribed mRNA sequence upstream of the internal 3 0 splice sites.
We used PCR primers in genomic sequence (Table 2 ) upstream of the 3 0 splice sites for exons hE1 N2 , hE1 N3 and hE1 N6 to determine whether each exon's promoter was active, avoiding the complication of upstream splicing activity as a contributing source of mRNA. In T47D cells, hE1 N2 (GenBank KJ651924), hE1 N3 (GenBank KJ651925) and hE1 N6 (GenBank KJ608382) first exons all contained mRNA sequence upstream of an internal 3 0 splice site (Fig. 9 ) marked by a consensus CAG trinucleotide (Zhang 1998) , indicating that the three promoters are all active in T47D cells. Consistent with our findings for pE1.3 in pigs, we found that promoter activity of its homologue hE1 N2 in human tissues was principally restricted to the kidneys and small intestine, with lower levels in the placenta, uterus, brain, lung and adrenal glands (Fig. 10A) confined to the kidneys (Fig. 10B) , and hE1 N3 spliced either directly to exon 2 or to exon hE1 N6 and then exon 2. Separately, we found that the exon hE1 N6 spliced either directly to exon 2 or spliced to hE1 N4 before splicing to exon 2 in T47D cells (GenBank KJ608383). However, no expression of hE1 N6 mRNA sequence upstream of the internal 3 0 splice site was recorded in the 20 human tissues analyzed (data not shown).
Comparative genomics reveals conserved exon and promoter sequences
Given that the homologous pE1/hE1 3 exons are conserved and expressed as first exons in multiple species, we hypothesised that the homologous pE1.3/hE1 N2 exons were also conserved and expressed in mRNAs encoding the PRLR of other species. Although no homologous sequence was present in any rodent species, we found that hE1 N2 /pE1.3 mRNA homologues had been sequenced for B. taurus (GenBank XM_005221579.1), C. lupus familiaris (GenBank XM_005619399.1), Papio anubis (GenBank FC171848.1), M. mulatta (GenBank XM_002804335.1) and Macaca fascicularis (GenBank XM_005556704 Expression of all pig PRLR exon 1.3 (pE1.3) transcripts in the different regions of the porcine small intestine. The duodenum, ileum and jejunum were dissected from four nulliparous female pigs, then the RNA was extracted and subjected to RT-qPCR analysis for pE1.3 mRNA expression using the total pE1.3/3 primer pair with normalisation for 18S rRNA expression levels. promoter elements within w800 bp of 5 0 sequences upstream of six pE1.3/hE1 N2 first exon homologues. As shown in Fig. 11 , there were seven conserved regions that ranged in homology from 57 to 100%. Conserved putative transcription binding sites within these regions include those for Sp1, Pit-1a, nuclear factor of activated T-cells, cytoplasmic 3 (NFATC3) and hepatocyte nuclear factor 1 (HNF1; Fig. 11 ). The conserved putative binding sites for HNF1, located just upstream of the transcription start site in the six pE1.3 homologues, matched either HNF1A (http://fantom.gsc.riken.jp/5/ sstar/JASPAR_motif:MA0046.1; 28 August 2014) or HNF1B
(http://fantom.gsc.riken.jp/5/sstar/JASPAR_Motif:MA0153.1; 28 August 2014) consensus binding site motifs.
Discussion
Understanding the responsiveness to PRL during various physiological states requires an accurate depiction of the genomic structure and transcriptional mechanisms that regulate PRLR expression. Through a comparative genomics approach, we have identified novel and conserved promoters that facilitate tissue-specific regulation of PRLR expression and splicing activity in pigs and Expression of the human PRLR first exon hE1 3 splicing to hE1 N2 in human tissues. Total RNA from 20 human tissues was subjected to RT then 40 cycles of PCR using primers in hE1 3 and hE1 N2 as given in Table 1 . Each sample was also subjected to 20 cycles of PCR using primers for 18S rRNA. Products were separated by electrophoresis on a 2% agarose gel. Cerebell, cerebellum; Fet, fetal: Saliv Gl, salivary gland; Sk Musc, skeletal muscle; Small Int, small intestine.
Figure 9
Sequences of three human PRLR first exons, hE1 N2 , hE1 N3 and the novel hE1 N6 (capital letters). Exon sequence included in transcripts as the result of both splicing machinery and promoter activity is underlined capitals and sequence transcribed only from the exon's own promoter (or included as intron sequence due to splicing from an upstream exon) is in italic capitals.
The internal 3 0 splice site CAG trinucleotides are indicated by ***. Additional intron and promoter sequences are in lower case. Nucleotides are numbered upstream from the ATG start codon in exon 3. The putative consensus binding site for HNF1 is indicated in bold lower case.
humans. Such a detailed analysis of how PRLR expression is regulated in different tissues has not been performed in any other species to date apart from the chicken. In that species, there are just two first exons: exon 1A, which is expressed in all 12 tissues, and, exon 1G, which is expressed only in the kidneys and small intestine (Bu et al. 2013) . Chicken exon 1G shares no sequence homology with pE1.3 or hE1 N2 , and its promoter shares no regions of homology with the mammalian sequences we aligned, apart from three putative HNF1A transcription factorbinding sites within the first 370 bp upstream of the transcription start site that are at different positions than the conserved HNF1A/1B binding site in the mammalian promoters (data not shown). Both HNF1A (http://fantom.gsc.riken.jp/5/sstar/EntrezGene:6927; 28 August 2014) and HNF1B (http://fantom.gsc.riken.jp/5/ sstar/EntrezGene:6928; 28 August 2014) are associated with gene expression in the human kidney, intestinal epithelium, and liver. Taken together, these data strongly suggest that the putative HNF1A/1B transcription factorbinding site in the promoters of the pE1.3 homologues, and the HNF1A sites in the chicken exon 1G promoter, are responsible for tissue-specific PRLR expression in the kidney, small intestine and kidney.
Our data point to a key role for pE1.3/hE1 N2 and its promoter in directing tissue-specific PRLR expression in kidney and small intestine. This tissue-restricted expression contrasts to that for other tissues having high levels of pPRLR including the MG, adrenal glands, endometrium, pituitary and placenta (Schennink et al. 2013) wherein the pE1 promoter is primarily active. For example, the pE1.3-containing transcripts are present in the kidneys of pigs at O530 000 copies mRNA/mg total RNA vs a lesser level of exon pE1 transcripts that are present at !130 000 copies mRNA/mg total RNA (Schennink et al. 2013) . Similarly, the abundance of pE1.3 transcripts in the small intestine (O145 000 copies mRNA/mg) markedly exceeds the !30 000 pE1 transcripts/mg total RNA (Schennink et al. 2013) . A similar quantitative and developmental analysis of the expression levels of the orthologous hE1 N2 in human tissues remains unlikely given the limited availability of such samples beyond the type of pooled or unreplicated specimens we used in this study. Such a quandary highlights the importance of studying these processes in a manipulable animal model, such as the pig, from which tissues can be readily sourced.
Two primary functions of PRL in the kidneys are calcium homeostasis (Wongdee & Charoenphandhu 2013) and natriuresis, where PRL inhibits Na C , K C -ATPase activity in the cortex via the renal dopamine system (Ibarra et al. 2005) . The kidneys are a major site of PRLR expression across species (Buck et al. 1992 , Nagano & Kelly 1994 , Peirce & Chen 2001 . Kidney function changes significantly during pregnancy alongside concomitant changes in the endocrine environment and haemodynamics, where women with chronic kidney disease have increased risk of pregnancy complications and infant morbidity (reviewed by Maynard & Thadhani (2009) Transcription of the human PRLR by promoters upstream of the alternative first exons (A) hE1 N2 and (B) hE1 N3 . Total RNA from 20 human tissues was reverse transcribed before (A) 38 cycles or (B) 40 cycles of PCR using primers in (A) hE1 N2 and exon 2 or (B) hE1 N3 and exon 5, as detailed in Table 1 .
Products were separated by electrophoresis on 2% agarose gels. Each sample was also subjected to 20 cycles of PCR using primers for 18S rRNA.
Abbreviations are as per Fig. 8 .
Figure 11
Promoter sequences for PRLR first exons with homology to pE1.3 and hE1 N2 from Sus scrofa (pig; pE1.3), Canis lupus familiaris (dog), Bos taurus (cow), Papio anubio (olive baboon), Macaca mulatta (Rhesus macaque) and Homo sapiens (hE1 N2 ). Shaded areas are regions of homology with the % homology indicated underneath. Transcription factor binding sites predicted to be in all promoter sequences are indicated above and below the sequence. Putative Sp1 sites were identified to be in slightly different positions in some species compared with others. Underlined bases are the consensus binding sites for HNF1. The boxed sequence is the start of the transcribed human exon hE1 N2 . Bases are numbered upstream from the known transcription start site.
pE1 (Schennink et al. 2013 ) increased from days 25 to 105 of gestation, while in mice PRLR-long form (LF) expression increases from day 18 of pregnancy to day 5 of lactation (Buck et al. 1992) . Interestingly, although pE1.3 expression was highest in the renal cortex where proximal tubules are located (Argenzio & Monteiro-Riviere 2001) , PRLR-LF in the kidneys of rats is expressed mostly in the inner strip of the outer medulla (Ouhtit et al. 1993) . This difference may reflect the superior ability of rodents to concentrate urine due to an increased relative length of the renal medulla (Argenzio & Monteiro-Riviere 2001) . Expression of pPRLR in the small intestine is dominated by the first exon pE1.3, indicating that the pE1.3 promoter is likely the main determinant of pPRLR-LF expression for this tissue in pigs. The small intestine plays crucial roles during lactation when the duodenum surface area increases along with its absorptive and digestive capacity. These changes occur alongside the secretion of acid and pepsin to meet the increased nutrient requirements and energy demand for milk synthesis (Lichtenberger & Trier 1979 , Hammond 1997 . Recent research has demonstrated multiple roles for PRL in the small intestine of mammals. In rodents, PRL mediates water uptake and retention during lactation in addition to the uptake of glucose, sodium, chloride and amino acids to support fluid, solute and energy requirements (Ramsey & Bern 1972 , Mainoya 1975 , Teerapornpuntakit et al. 2012 . Both active and passive transport mechanisms of calcium uptake are rapidly stimulated by PRL via the phosphoinositide 3-kinase pathway (Jantarajit et al. 2007 , Ryszka et al. 2012 ). In addition, PRL increases the expression of genes such as CLDN19, which modulates paracellular permeability, FGFR2C, which is required for differentiation and the sodium pump ATP1B2, which is essential for intestinal transport of glucose and calcium (Teerapornpuntakit et al. 2014) . Despite these clear effects of PRL on the intestine, there are few data regarding the action of PRL via PRLR in the small intestines of livestock or humans.
A unique finding from our studies is the restricted expression of one specific pPRLR first exon transcript in the heart of pigs, namely pE1.5/2/3. Lactating females have elevated cardiac output (Hanwell & Linzell 1973 , Peaker 1976 , Ota & Peaker 1979 , which increases nutrient and water delivery to the MG, liver and gastrointestinal tract (Chatwin et al. 1969) , where PRL increases the force and rate of contractions in heart tissue (Nassar et al. 1974 , Karmazyn et al. 1982 . In humans, peripartum cardiomyopathy occurs in late pregnancy/early lactation and leads to a 6-10% mortality rate (Bhattacharyya et al. 2012) . One proposed cause of this idiopathic heart failure is local cleavage of PRL to its 16 kDa form, where pharmacologic inhibition of PRL secretion successfully treats the condition (Bachelier-Walenta et al. 2013) . Data from previous studies indicate that expression of PRLR in random adult human hearts is relatively low (Kline et al. 1999 , Fagerberg et al. 2014 , while the factors that regulate PRLR expression in the human heart are unknown. The pE1.5 promoter is the principal determinant of total pPRLR expression in the porcine heart. For example, there were O65 000 copies of pE1.5 mRNA/mg total RNA in the heart and !12 500 copies of pE1 mRNA/mg total RNA, the next most abundant first exon. The factors that regulate the cardiac-specific splicing of pE1.5/2/3 remain to be resolved; however, our data demonstrate that PRLR expression from the pE1.5 promoter is not restricted to the heart, unlike the pE1.3 promoter that is active only in the kidney/small intestine/liver.
Our findings also emphasise that the mRNA splicing pattern for pPRLR first exons is tissue-specific. For example, abundance of the pE1.5/3 transcript was highest in the MG and lowest in the skeletal muscle, a pattern present in nearly 50% of the transcripts, whereas the pE1.5/2/3 transcript (and to some extent the pE1.5/2/2.1/3 transcript) was enriched in the heart but not in any other tissue. Along similar lines, the pE1.6/2/3 transcript, but not pE1.6/3 or pE1.6/2/2.1/3, was enriched in the kidney. Likewise, the pE1.3/3 and pE1.3/2/3 transcripts were most highly expressed in the kidney followed by the small intestine and then the liver, whereas the pE1.3/2/2.1/3 transcript was most highly expressed in the kidney followed by the liver, and was absent from the small intestine. Tissuespecific splicing, which incorporates up to eight different types of alternative splicing events (Wang et al. 2008) , has been extensively analyzed using microarrays in budding yeast and metazoans and using RNA-seq in human cell lines and tissues (Calarco et al. 2011) . Our data indicate an even more complicated level of mRNA splicing for the pPRLR gene, where the final mRNA composition not only depends on which tissue the transcript is expressed in but also on which first exon is transcribed. An example is the inclusion or absence of exon 2, where the pE1.8/3 transcript was not detected in any tissues while the pE1.8/2/3 transcript was present at 4-60 copies mRNA/mg total RNA in all 18 tissues. Conversely, the pE1.7b/3 transcript was expressed at 100-1000 copies mRNA/mg total RNA in all tissues, whereas pE1.7b/2/3 was present at only 0-250 copies mRNA/mg total RNA. These data support the presence of an interaction between the splicing and transcriptional machineries, which occurs by two main mechanisms: i) transcription can be coupled with splicing by the recruitment of splicing factors to the promoter or ii) changes in the rate of transcription can alter splicing due to, for example, changes in the pre-mRNA chromatin structure as a result of different first exon sequences, or by different rates of transcription from alternate promoters (Kornblihtt 2007) . Further experiments are required to establish precisely how this tissue-specific and first exon-dependent alternative splicing of the pPRLR is being regulated.
